{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["15(3)"],"submitter":["Tamura RK"],"pubmed_abstract":["<h4>Introduction</h4>It is challenging for pregnant women with type 1 diabetes to maintain optimum glucose level to attain good neonatal outcomes. This study evaluated the efficacy of sensor-augmented insulin pump (SAP) with a predictive low-glucose suspend (PLGS) system in pregnant Japanese women with type 1 diabetes.<h4>Materials and methods</h4>SAP with PLGS was used in 11 of the 22 women with type 1 diabetes who delivered between 2011 and 2021 at the two medical institutions in Japan. Glucose management, insulin delivery suspension time (IST) and neonatal outcomes were retrospectively studied.<h4>Results</h4>In SAP with PLGS cases (<i>n</i> = 11), average glycated hemoglobin levels were < 6.5% throughout the pregnancy, and the time in range (TIR, 63-140 mg/dl) was > 70% in the second a"],"journal":["Diabetology international"],"pagination":["447-455"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11291783"],"repository":["biostudies-literature"],"pubmed_title":["A sensor-augmented pump with a predictive low-glucose suspend system could lead to an optimal time in target range during pregnancy in Japanese women with type 1 diabetes."],"pmcid":["PMC11291783"],"pubmed_authors":["Kodani N","Tamura RK","Kajio H","Itoh H","Itoh A","Meguro S"],"additional_accession":[]},"is_claimable":false,"name":"A sensor-augmented pump with a predictive low-glucose suspend system could lead to an optimal time in target range during pregnancy in Japanese women with type 1 diabetes.","description":"<h4>Introduction</h4>It is challenging for pregnant women with type 1 diabetes to maintain optimum glucose level to attain good neonatal outcomes. This study evaluated the efficacy of sensor-augmented insulin pump (SAP) with a predictive low-glucose suspend (PLGS) system in pregnant Japanese women with type 1 diabetes.<h4>Materials and methods</h4>SAP with PLGS was used in 11 of the 22 women with type 1 diabetes who delivered between 2011 and 2021 at the two medical institutions in Japan. Glucose management, insulin delivery suspension time (IST) and neonatal outcomes were retrospectively studied.<h4>Results</h4>In SAP with PLGS cases (<i>n</i> = 11), average glycated hemoglobin levels were < 6.5% throughout the pregnancy, and the time in range (TIR, 63-140 mg/dl) was > 70% in the second a","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Jul","modification":"2025-06-25T03:04:23.389Z","creation":"2025-06-25T03:04:23.389Z"},"accession":"S-EPMC11291783","cross_references":{"pubmed":["39101163"],"doi":["10.1007/s13340-024-00716-7"]}}